ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00283218
Recruitment Status : Completed
First Posted : January 27, 2006
Last Update Posted : August 8, 2006
Sponsor:
Collaborator:
Novo Nordisk A/S
Information provided by:
University of Aarhus